BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1891063)

  • 1. Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders.
    Kalaria RN; Galloway PG; Perry G
    Neuropathol Appl Neurobiol; 1991 Jun; 17(3):189-201. PubMed ID: 1891063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
    Ferrer I; Freixas M; Blanco R; Carmona M; Puig B
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):329-37. PubMed ID: 15305978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration.
    Dickson DW; Feany MB; Yen SH; Mattiace LA; Davies P
    J Neural Transm Suppl; 1996; 47():31-46. PubMed ID: 8841955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease.
    Kalaria RN; Grahovac I
    Brain Res; 1990 May; 516(2):349-53. PubMed ID: 2364299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders.
    Smith TW; Lippa CF
    J Neuropathol Exp Neurol; 1995 May; 54(3):297-303. PubMed ID: 7745428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease.
    Mann DM; Jones D; Prinja D; Purkiss MS
    Acta Neuropathol; 1990; 80(3):318-27. PubMed ID: 1698007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
    Coria F; Castaño EM; Frangione B
    Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodetection of the amyloid P component in Alzheimer's disease.
    Duong T; Pommier EC; Scheibel AB
    Acta Neuropathol; 1989; 78(4):429-37. PubMed ID: 2551124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
    Coria F; Castaño E; Prelli F; Larrondo-Lillo M; van Duinen S; Shelanski ML; Frangione B
    Lab Invest; 1988 Apr; 58(4):454-8. PubMed ID: 2965774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Morrison JH
    Acta Neuropathol; 1994; 87(2):115-24. PubMed ID: 8171960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
    Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
    Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid P component and other acute-phase proteins associated with cerebellar A beta-deposits in Alzheimer's disease.
    Kalaria RN; Perry G
    Brain Res; 1993 Dec; 631(1):151-5. PubMed ID: 7507788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
    Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
    Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
    Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.
    Dickson DW; Crystal H; Mattiace LA; Kress Y; Schwagerl A; Ksiezak-Reding H; Davies P; Yen SH
    Acta Neuropathol; 1989; 78(6):572-84. PubMed ID: 2683563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical evidence for the lack of amyloid P component in some intracerebral amyloids.
    Westermark P; Shirahama T; Skinner M; Brun A; Cameron R; Cohen AS
    Lab Invest; 1982 May; 46(5):457-60. PubMed ID: 7043084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA sequestration to pathological lesions of neurodegenerative diseases.
    Ginsberg SD; Galvin JE; Chiu TS; Lee VM; Masliah E; Trojanowski JQ
    Acta Neuropathol; 1998 Nov; 96(5):487-94. PubMed ID: 9829812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum amyloid P in Alzheimer's disease. Implications for dysfunction of the blood-brain barrier.
    Kalaria RN; Golde TE; Cohen ML; Younkin SG
    Ann N Y Acad Sci; 1991; 640():145-8. PubMed ID: 1776732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.